AI assistant
Sending…
EXAGEN INC. — Director's Dealing 2023
Feb 10, 2023
33644_dirs_2023-02-10_265cb7c2-980b-4b35-ac50-640c56b1b236.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2023-02-08
Reporting Person: Hazeltine Mark (Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-08 | Common Stock | S | 5821 | $2.6924 | Disposed | 93872 | Direct |
Footnotes
F1: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.
More from EXAGEN INC.
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 11
Earnings Release
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Board/Management Information
2026
Apr 23
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11